![](/img/cover-not-exists.png)
An Evaluation Of The Budget Impact Of The New 20% Subcutaneous Immunoglobulin (IG20GLY) For The Management Of Primary Immunodeficiency Diseases In Switzerland
Pollock, RF, Meckley, LMVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.854
Date:
October, 2017
File:
PDF, 58 KB
english, 2017